By Giulia Petroni

The European Medicines Agency said Thursday that it has approved two additional manufacturing sites for the production of the Covid-19 vaccine developed by Pfizer Inc. and BioNTech SE.

The sites, which will manufacture the finished product, are set to provide up to 50 million additional doses of Comirnaty by 2021, according to the EU agency.

One site is operated by Sanofi-Aventis Deutschland GmbH, while the other by Siegfried Hameln GmbH. They are both located in Germany.

The European Medicines Agency said the sites can become operational immediately, as the recommendation doesn't require a decision from the European Commission.

Write to Giulia Petroni at giulia.petroni@wsj.com

(END) Dow Jones Newswires

September 09, 2021 12:41 ET (16:41 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Grafico Azioni Sanofi (EU:SAN)
Storico
Da Mar 2024 a Apr 2024 Clicca qui per i Grafici di Sanofi
Grafico Azioni Sanofi (EU:SAN)
Storico
Da Apr 2023 a Apr 2024 Clicca qui per i Grafici di Sanofi